
The Keap1-Nrf2 pathway, a key regulator of cellular response to oxidative stress, is implicated in melanoma. Abnormalities in Nrf2 expression influence melanoma development; decreased levels may raise the risk, while overexpression leads to aggressive, metastatic, and therapy-resistant tumors. Understanding these dual roles provides insights for potential therapeutic interventions targeting the Keap1-Nrf2 pathway in melanoma.
Like
Save
Share